Progression of pancreatic neuroendocrine tumors (PanNETs) to metastatic disease is associated with MCT4 expression and metabolic heterogeneity

被引:0
|
作者
Sadowski, M. [1 ]
Brautigam, K. [1 ]
Straub, J. [1 ]
Andreasi, V [2 ]
Kirchner, P. [1 ]
Maire, R. [1 ]
Dettmer, M. [1 ]
Schrader, J. [3 ]
Partelli, S. [2 ]
Falconi, M. [2 ]
Marinoni, I [1 ]
Perren, A. [1 ]
机构
[1] Univ Bern, Bern, Switzerland
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
关键词
mct4; metabolic subtypes; aggressive pannet; patient-derived tumoroid;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
F19
引用
收藏
页码:149 / 149
页数:1
相关论文
共 50 条
  • [21] Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors
    Awwad, Fayez
    Ozga, Ann-Kathrin
    Amin, Tania
    Schlueter, Catarina
    Kailani, Sajeda
    Perez, Daniel
    Wolter, Stefan
    Sauter, Guido
    Izbicki, Jakob
    Lohse, Ansgar Wilhelm
    Schrader, Joerg
    NEUROENDOCRINOLOGY, 2022, 112 (12) : 1225 - 1236
  • [22] Loss of UCHL1 Expression Increases Metastatic Potential in Pancreatic Neuroendocrine Tumors
    Finnerty, Brendan
    Moore, Maureen
    Min, Irene
    Seandel, Marco
    Evans, Todd
    Zarnegar, Rasa
    Fahey, Thomas
    PANCREAS, 2017, 46 (03) : 427 - 428
  • [23] Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling
    Tran, Catherine G.
    Scott, Aaron T.
    Li, Guiying
    Sherman, Scott K.
    Ear, Po Hien
    Howe, James R.
    SURGERY, 2021, 169 (01) : 155 - 161
  • [24] Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites
    Kimura, Hideyo
    Ohtsuka, Takao
    Fujimoto, Takaaki
    Date, Kenjiro
    Matsunaga, Taketo
    Cases, Ana Ines
    Abe, Atsushi
    Mizuuchi, Yusuke
    Miyasaka, Yoshihiro
    Ito, Tetsuhide
    Oda, Yoshinao
    Nakamura, Masafumi
    Tanaka, Masao
    PANCREAS, 2016, 45 (07) : 947 - 952
  • [25] Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling
    Tran, C.
    Scott, A.
    Li, G.
    Sherman, S.
    Ear, P. H.
    Howe, J.
    PANCREAS, 2021, 50 (03) : 441 - 441
  • [26] Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents
    Scott, Aaron
    Weitz, Michelle
    Breheny, Patrick
    Ear, Po Hien
    Darbro, Benjamin
    Brown, Bart
    Braun, Terry
    Li, Guiying
    Amjad, Ume Salma Shaik
    Kaemmer, Courtney
    Maharjan, Chandra Kumar
    Quelle, Dawn
    Bellizzi, Andrew
    Dillon, Joseph
    O'Dorisio, Thomas
    Howe, James
    PANCREAS, 2020, 49 (03) : 485 - 485
  • [27] A Prospective Analysis of DAXX/ATRX Testing for Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression for DAXX/ATRX is Associated with the Development of Metastatic Disease
    Bell, Phoenix
    Smith, Katelyn
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1815 - S1816
  • [28] Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases
    Keck, Kendall J.
    Breheny, Patrick
    Braun, Terry A.
    Darbro, Benjamin
    Li, Guiying
    Dillon, Joseph S.
    Bellizzi, Andrew M.
    O'Dorisio, Thomas M.
    Howe, James R.
    SURGERY, 2018, 163 (01) : 232 - 238
  • [29] Gene Expression Changes in Small Bowel Neuroendocrine Tumors Associated With Progression to Metastases
    Keck, Kendall
    Breheny, Patrick
    Braun, Terry
    Darbro, Benjamin
    Li, Guiying
    Dillon, Joseph
    Bellizzi, Andrew
    O'Dorisio, Thomas
    Howe, James
    PANCREAS, 2018, 47 (03) : 343 - 344
  • [30] MYC upregulates MCT4 expression and promotes metabolic reprogramming and enhanced lactate utilization in LKB1-deficient NSCLC
    Qian, Yu
    Molkentine, David
    Kong, Yifan
    Huang, Qian
    Yang, Chendong
    Poteete, Alissa
    Guimaraes, Alvaro P.
    Jiang, Peixin
    Skoulidis, Ferdinandos
    Reuben, Alexandre
    Minna, John D.
    DeBerardinis, Ralph J.
    Heymach, John V.
    CANCER RESEARCH, 2024, 84 (06)